Biotechnology CRISPR Therapeutics Reports Positive Top-Line Results from Its Phase 1 CARBON Trial of CTX110(TM) in Relapsed or Refractory CD19+ B-cell Malignancies October 21, 2020
Biotechnology FILING DEADLINE–Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of BMRN, BTU, CACC and TRQ October 20, 2020
Biotechnology RETA INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit has been Filed Against Reata Pharmaceuticals Inc. October 20, 2020
Biotechnology IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Reata Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm October 20, 2020
Biotechnology IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Reata Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm October 19, 2020
Metals & Mining SHAREHOLDER ALERT: CLAIMSFILER REMINDS BMRN, BTU, CACC, TRQ INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits October 19, 2020
Biotechnology Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against BioMarin Pharmaceuticals, Inc. (BMRN) October 19, 2020
Search
Biotechnology
